Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions)

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2017 Oct 13

PMID 29023422

Citations 34

Authors

Maria Serena Fabbrini

Miku Katayama

Ikuhiko Nakase

Riccardo Vago

Affiliations

Soon will be listed here.

Abstract

Plant ribosome-inactivating protein (RIP) toxins are EC3.2.2.22 N-glycosidases, found among most plant species encoded as small gene families, distributed in several tissues being endowed with defensive functions against fungal or viral infections. The two main plant RIP classes include type I (monomeric) and type II (dimeric) as the prototype ricin holotoxin from that is composed of a catalytic active A chain linked via a disulphide bridge to a B-lectin domain that mediates efficient endocytosis in eukaryotic cells. Plant RIPs can recognize a universally conserved stem-loop, known as the α-sarcin/ ricin loop or SRL structure in 23S/25S/28S rRNA. By depurinating a single adenine (A4324 in 28S rat rRNA), they can irreversibly arrest protein translation and trigger cell death in the intoxicated mammalian cell. Besides their useful application as potential weapons against infected/tumor cells, ricin was also used in bio-terroristic attacks and, as such, constitutes a major concern. In this review, we aim to summarize past studies and more recent progresses made studying plant RIPs and discuss successful approaches that might help overcoming some of the bottlenecks encountered during the development of their biomedical applications.

Citing Articles

Characterization of MAP c21873-1 as a new counter-selectable marker for unmarked genetic modification of Pichia pastoris.

Liu M, Zhou S, Cao Y, Yang K, Xiao Y, Wang W Microb Cell Fact. 2024; 23(1):224.

PMID: 39118053 PMC: 11312372. DOI: 10.1186/s12934-024-02496-w.

Novel loading protocol combines highly efficient encapsulation of exogenous therapeutic toxin with preservation of extracellular vesicles properties, uptake and cargo activity.

Zuppone S, Zarovni N, Noguchi K, Loria F, Morasso C, Lohmus A Discov Nano. 2024; 19(1):76.

PMID: 38691254 PMC: 11063024. DOI: 10.1186/s11671-024-04022-8.

Antifungal Activity of Ribosome-Inactivating Proteins.

Iglesias R, Citores L, Gay C, Ferreras J Toxins (Basel). 2024; 16(4).

PMID: 38668617 PMC: 11054410. DOI: 10.3390/toxins16040192.

Biocontrol Potential of Sodin 5, Type 1 Ribosome-Inactivating Protein from L. Seeds.

Novak Babic M, Ragucci S, Leonardi A, Pavsic M, Landi N, Krizaj I Biomolecules. 2024; 14(3).

PMID: 38540756 PMC: 10967906. DOI: 10.3390/biom14030336.

Heterophyllin: A New Adenia Toxic Lectin with Peculiar Biological Properties.

Bortolotti M, Biscotti F, Zanello A, Polito L, Bolognesi A Toxins (Basel). 2024; 16(1).

PMID: 38276525 PMC: 10820617. DOI: 10.3390/toxins16010001.

References

Vitale A, Boston R . Endoplasmic reticulum quality control and the unfolded protein response: insights from plants. Traffic. 2008; 9(10):1581-8. DOI: 10.1111/j.1600-0854.2008.00780.x. View

Kooijmans S, Schiffelers R, Zarovni N, Vago R . Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment. Pharmacol Res. 2016; 111:487-500. DOI: 10.1016/j.phrs.2016.07.006. View

Olsen E, Duvic M, Frankel A, Kim Y, Martin A, Vonderheid E . Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol. 2001; 19(2):376-88. DOI: 10.1200/JCO.2001.19.2.376. View

Lodge J, Kaniewski W, Tumer N . Broad-spectrum virus resistance in transgenic plants expressing pokeweed antiviral protein. Proc Natl Acad Sci U S A. 1993; 90(15):7089-93. PMC: 47081. DOI: 10.1073/pnas.90.15.7089. View

Day P, Pinheiro T, Roberts L, Lord J . Binding of ricin A-chain to negatively charged phospholipid vesicles leads to protein structural changes and destabilizes the lipid bilayer. Biochemistry. 2002; 41(8):2836-43. DOI: 10.1021/bi012012i. View

Knight B . Ricin--a potent homicidal poison. Br Med J. 1979; 1(6159):350-1. PMC: 1597717. View

Vandenbussche F, Peumans W, Desmyter S, Proost P, Ciani M, Van Damme E . The type-1 and type-2 ribosome-inactivating proteins from Iris confer transgenic tobacco plants local but not systemic protection against viruses. Planta. 2004; 220(2):211-21. DOI: 10.1007/s00425-004-1334-2. View

Wiley R, Oeltmann T, Lappi D . Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor. Brain Res. 1991; 562(1):149-53. DOI: 10.1016/0006-8993(91)91199-b. View

Martin V, Cortes M, de Felipe P, Farsetti A, Calcaterra N, Izquierdo M . Cancer gene therapy by thyroid hormone-mediated expression of toxin genes. Cancer Res. 2000; 60(12):3218-24. View

10.

Araki N, Hamasaki M, Egami Y, Hatae T . Effect of 3-methyladenine on the fusion process of macropinosomes in EGF-stimulated A431 cells. Cell Struct Funct. 2006; 31(2):145-57. DOI: 10.1247/csf.06029. View

11.

Conde-Vancells J, Rodriguez-Suarez E, Embade N, Gil D, Matthiesen R, Valle M . Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res. 2009; 7(12):5157-66. PMC: 2696236. DOI: 10.1021/pr8004887. View

12.

Yoshida T, Chen C, Zhang M, Wu H . Disruption of the Golgi apparatus by brefeldin A inhibits the cytotoxicity of ricin, modeccin, and Pseudomonas toxin. Exp Cell Res. 1991; 192(2):389-95. DOI: 10.1016/0014-4827(91)90056-z. View

13.

Sokolova V, Ludwig A, Hornung S, Rotan O, Horn P, Epple M . Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces. 2011; 87(1):146-50. DOI: 10.1016/j.colsurfb.2011.05.013. View

14.

Wen J, Yan M, Liu Y, Li J, Xie Y, Lu Y . Specific Elimination of Latently HIV-1 Infected Cells Using HIV-1 Protease-Sensitive Toxin Nanocapsules. PLoS One. 2016; 11(4):e0151572. PMC: 4822841. DOI: 10.1371/journal.pone.0151572. View

15.

van Dommelen S, Vader P, Lakhal S, Kooijmans S, van Solinge W, Wood M . Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release. 2011; 161(2):635-44. DOI: 10.1016/j.jconrel.2011.11.021. View

16.

Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T . Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013; 165(2):77-84. DOI: 10.1016/j.jbiotec.2013.03.013. View

17.

Zhang D, Wang J, Xu D . Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems. J Control Release. 2016; 229:130-139. DOI: 10.1016/j.jconrel.2016.03.020. View

18.

Krajewski S, Krajewska M, Ellerby L, Welsh K, Xie Z, Deveraux Q . Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci U S A. 1999; 96(10):5752-7. PMC: 21932. DOI: 10.1073/pnas.96.10.5752. View

19.

Valbonesi P, Barbieri L, Bolognesi A, Bonora E, Polito L, Stirpe F . Preparation of highly purified momordin II without ribonuclease activity. Life Sci. 1999; 65(14):1485-91. DOI: 10.1016/s0024-3205(99)00389-6. View

20.

Baker N, Sept D, Joseph S, Holst M, McCammon J . Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A. 2001; 98(18):10037-41. PMC: 56910. DOI: 10.1073/pnas.181342398. View